Webinar
live
17
Jul
2024
18
00
CEST
Gastrointestinal cancer highlights from AACR Annual Meeting 2024, ASCO Annual Meeting 2024, and ESMO GI Cancers Congress 2024
Gastrointestinal (GI) cancers are among the most common and deadly worldwide. Recent advancements in minimally invasive surgery, targeted therapies, and immunotherapy are improving survival rates. Molecular insights are driving personalised treatment approaches, significantly enhancing patient outcomes. This webinar will explore these breakthroughs and future directions in GI cancer care.

Speakers
Discussant
Ducreux Michel

Head of GI Oncology Unit, Department of Medical Oncology, at Gustave Roussy, Villejuif, France
Expert
Macarulla Teresa

Group Leader of Gastrointestinal and Endocrine Tumors Group and Noncolorectal GI Cancer Translational Research Group at the Vall d'Hebron University Hospital, Barcelona, Spain
Expert
Smyth Elizabeth

Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom